Market numbers you can defend in the boardroom.
Vectomat Insights sizes markets bottom-up, validates them top-down, and has every figure reviewed by a sector specialist. Ten-year forecasts, country-level splits and named evidence behind each claim, starting with healthcare and life sciences.
Long-Acting Injectable Pharmaceuticals Market Size, Share & Growth
The Global Long-Acting Injectable Pharmaceuticals market was valued at USD 12,642.7 Mn in 2025 and is projected to reach USD 35,129.3 Mn by 2035, growing at a 10.76% CAGR, according to Vectomat Insights. North America leads with 39.0% of revenue, microspheres are the largest product type at 32.0%, and implants grow fastest at 15.1% a year.

Are AI-generated market reports accurate enough to base decisions on?
They are useful for a first look, but not for decisions that commit budget. AI-generated market reports usually blend published estimates they cannot trace, miss recent deals and approvals, and have no one accountable for the numbers. A VMI report is built bottom-up from company, volume and price data, checked in expert interviews, reviewed by a sector specialist, and customised to your question.
We use AI too, to speed up data collection and checks. Our analysts own every number.
Read: Human Analysis vs AI-Based Analysis — why human judgment still matters →| What to check | Typical AI-generated report | VMI analyst-led report |
|---|---|---|
| Where the numbers come from | Blends published estimates of unknown origin; sources often can't be traced | Built bottom-up from company revenue, volumes and prices, then checked top-down against industry totals |
| Do the numbers add up? | Segments, regions and countries often don't reconcile to one total | Every segment, region and country split reconciles to the same market total |
| How current it is | Limited by training or indexing dates; misses recent deals, approvals and policy changes | Dated, named developments up to publication, with the source for each |
| Primary research | None | Interviews with buyers, clinicians, manufacturers, distributors and investors |
| Expert review | None | Written by a sector analyst, signed off by a research manager with 9–10+ years' experience |
| Risk of invented facts | Can produce plausible figures, companies or citations that don't exist | Named sources and a published method you can audit |
| Fit to your question | Generic segments and regions | Up to 10% free customization: your countries, segments and competitors |
| Someone to ask | No one stands behind the figures | An analyst call to walk through any assumption |
Which do you need?
Learning a market's vocabulary or rough scale
An AI summary or a free VMI sample is enough.
Market entry, capex, M&A, fundraising, board papers
Use an analyst-validated report you can cite and defend.
One country, segment, competitor set or price point
Ask for a customised cut or a custom study.
Industries we cover
One method across every industry, with an estimation model fitted to each: patients and doses in pharma, installed base in devices, capacity and utilisation in industrial markets.
Healthcare & Life Sciences
Pharmaceuticals, medical devices, diagnostics, biotechnology, advanced therapies and healthcare services.
Chemicals & Materials
Specialty and commodity chemicals, polymers, advanced materials and coatings.
Technology, Media & Telecom
Software, cloud, AI, cybersecurity, IT services, media and telecom networks.
Semiconductors & Electronics
Chips, components, sensors, displays and consumer electronics.
Energy & Power
Renewables, storage, oil and gas, hydrogen, grid and power equipment.
Automotive & Transportation
Vehicles, EVs, components, mobility services, logistics and rail.
Aerospace & Defense
Commercial aviation, space, defense systems and MRO.
Consumer Goods & Retail
Personal care, household products, apparel, e-commerce and retail.
All industries
See the full coverage map, or ask for a market we don't list yet.
New reports
Long-Acting Injectable Pharmaceuticals Market Size, Share & Growth
The Global Long-Acting Injectable Pharmaceuticals market was valued at USD 12,642.7 Mn in 2025 and is projected to reach USD 35,129.3 Mn by 2035, growing at a 10.76% CAGR, according to Vectomat Insights. North America leads with 39.0% of revenue, microspheres are the largest product type at 32.0%, and implants grow fastest at 15.1% a year.
Medical Nonwoven Products Market Size, Share & Growth 2026–2035
The Global Medical Nonwoven Products market was valued at USD 1,372.4 Mn in 2025 and is projected to reach USD 3,772.3 Mn by 2035, growing at a 10.64% CAGR during 2026–2035, according to Vectomat Insights. North America leads with a 31.0% share, surgical gowns & drapes are the largest product category at 32.0%, and Asia Pacific is the fastest-growing region.
Remote Patient Monitoring Services Market Size, Share & Forecast
The Global Remote Patient Monitoring Services market was valued at USD 12,486.2 Mn in 2025 and will reach USD 49,945.5 Mn by 2035, a 14.87% CAGR, according to Vectomat Insights. North America leads with 47.0% of revenue, devices hold the largest component share at 44.0%, and outsourced clinical monitoring services are the fastest-growing component at 20.86% a year.
Tissue Engineering Market Size, Share, Growth & Forecast 2026–2035
The Global Tissue Engineering market was valued at USD 1,487.3 Mn in 2025 and is projected to reach USD 5,129.7 Mn by 2035, growing at a 13.18% CAGR during 2026–2035, according to Vectomat Insights. North America leads with a 45.06% share, Asia Pacific grows fastest, and Scaffolds & Biomaterials remain the dominant product type at 42.0%.
Serum-Free Cell Culture Media Market Size, Growth & Forecast 2026–2035
The Global Serum-Free Cell Culture Media market was valued at USD 1,268.9 Mn in 2025 and is projected to reach USD 3,516.3 Mn by 2035, growing at a 10.73% CAGR during 2026–2035, according to Vectomat Insights. North America leads with a 36.0% share, ready-to-use media hold 52.0% of revenue, and Asia Pacific is the fastest-growing region as South Korea scales biologics capacity.
Digital PCR Market Report: Size, Share & Trends 2026-2035
The Global Digital PCR market was valued at USD 1,843.6 Mn in 2025 and will reach USD 5,206.5 Mn by 2035, a 10.94% CAGR. Instruments hold 44.0% of revenue today, but reagents and consumables overtake them by 2035. North America leads with 41.0%. Oncology testing is the largest application, and infectious disease testing grows fastest at 14.58% a year.
More depth than the typical market report
A side-by-side of what a VMI report contains against the industry norm.
| Dimension | VMI | Typical |
|---|---|---|
| Report Pages | 300+ | ~120 pages |
| Forecast Horizon | 10 years | 7 years |
| Segmentation Dims | 4 dims | 4-5 dimensions |
| Historical Data | 3 years | 4-5 years |
| Country Coverage | 35+ countries | 15-18 countries |
| Companies Profiled | 15 companies | 10-12 companies |
| DROC Framework | Full (4 elem) | Drivers only |
Sixteen steps from scope to forecast
Bottom-up builds, top-down checks, expert interviews and triangulation. Every report follows the same audited path.
- Market Definition & Scope
- Segmentation Framework
- Company & Product Mapping
- Demand-Side Assessment
- Supply-Side Assessment
- Volume / Patient / Procedure / Installed Base Analysis
- Pricing & Revenue Benchmarking
- Company Revenue Assessment
Built for the people who sign off the numbers
Strategy & corporate development
Market entry, portfolio and M&A screening with defensible market sizes.
Investors & analysts
Commercial due diligence and sector theses with country-level forecasts.
Product & marketing teams
Segment demand, pricing benchmarks and competitor positioning.
Consultants & advisers
Data packs and models to plug into client work, with free customization.
Organizations our analysts have worked with
Our research team has delivered market studies for 80+ organizations across consulting, investment, pharma, chemicals, technology and industry, at Vectomat Insights and in earlier roles. A selection:
- Boston Consulting Group
- EY
- PwC
- AlixPartners
- L.E.K. Consulting
- Piper Sandler
- New Enterprise Associates
- Suvretta Capital
- Praxis Global Alliance
- Mutual of Omaha
- Samsung
- Anritsu
- SCSK
- Nuvoton
- Pfizer
- Danaher
- BASF
- Jabil
- PathAI
- Virbac
- Daicel
- Tenneco
- Berlin Packaging
- Escorts
- Fagor Ederlan
- Prayon
- Intelcia
- Parts Town
Need a number you can defend?
Tell us the market, the geography and the decision. We'll scope a syndicated report, a custom cut, or a fresh study.